Article: article from journal or magazin.
Épidémiologie et physiopathologie de la rétinopathie du prématuré [Epidemiology and pathophysiology of retinopathy of prematurity].
Archives De Pédiatrie : Organe Officiel De La Sociéte Française De Pédiatrie
18 Suppl 2
Publication types: English Abstract ; Journal ArticlePublication Status: ppublish
Retinopathy of prematurity (ROP) is a major cause of visual impairment in premature infants. It is characterized by an arrest in normal retinal vascular development associated with microvascular degeneration, followed by an abnormal hypoxiainduced neovascularization. Recent studies point out that ROP is a multifactorial disease, implicating both oxygen-dependent and oxygen-independent mechanisms. Oxygen-dependent factors leading to microvascular degeneration include generation of reactive oxygen species and suppression of specific oxygen-regulated vascular survival factors, such as vascular endothelial growth factor (VEGF) and erythropoietin. The other major mechanism for the initial capillary loss is oxygen-independent and implicates a deficit in growth factor IGF-1/IGFBP3. The proliferative, second phase of ROP is triggered by increases in vascular growth factors concentrations, in an attempt to compensate for the hypoxic retina. Novel signaling pathways for vascular repair, implicating both metabolite signaling and inflammatory lipids signaling, represent new therapeutic avenues for ROP.
Humans, Infant, Newborn, Insulin-Like Growth Factor I/metabolism, Oxidative Stress/physiology, Oxygen Inhalation Therapy/adverse effects, Reactive Oxygen Species/metabolism, Retinal Neovascularization, Retinopathy of Prematurity/epidemiology, Retinopathy of Prematurity/physiopathology, Vascular Endothelial Growth Factor A/metabolism
Web of science
Last modification date